Diagnostics company releases biomarker panel for type 1 diabetes detection

08/16/2013 | MedCityNews.com

Genalyte has introduced its first biomarker panel that can detect type 1 diabetes early by measuring seven autoantibodies linked to destroyed pancreatic islet cells seen in patients with the condition. The disposable silicon chip-based test, which takes only 15 minutes to generate results, was developed using a $500,000 Small Business Innovation Research grant received by the company last year.

View Full Article in:

MedCityNews.com

Published in Brief:

SmartBrief Job Listings for Health Care

Job Title Company Location
Senior Director, Research
America's Health Insurance Plans (AHIP)
Washington, DC
Senior Director, Research
America's Health Insurance Plans (AHIP)
Washington, DC
Director, Quality Regulatory Affairs
Cardinal Health
Chicago, IL
Regional Director, Southeastern Region - State Affairs
America's Heatlh Insurance Plans (AHIP)
Washington, DC
Regional Director, Southeastern Region - State Affairs
America's Heatlh Insurance Plans (AHIP)
Washington, DC